CF

Cardiac Failure Review

Cardiac Failure Review is a journal-focused site presenting current volume content, review articles, original research, editorials, news, webinars, and video series in heart failure and related cardiovascular topics.

Looking to publish in Cardiac Failure Review? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Try Livewrite Now
Subject Cardiac & Cardiovascular Systems
Impact Factor 5.7
Quartile Q1
Open Access Type Open
ISSN 2057-7540
eISSN 2057-7559
Invitation Only No
Cost Range Review article and original research: £2400 / €2800 / $3030; Expert opinion: £1800 / €2100 / $2273; Editorial, letter to editor, and viewpoint: no fee; CC BY 4.0 option for UKRI and Wellcome Trust funded submissions: £2800 / €3270 / $3535.

Submission Instructions

Cardiac Failure Review accepts the following article types. Click on an article type to view submission instructions.

Review Article

Cover Letter Cover Letter requirements are not specified.
Abstract An unstructured abstract is required for Review Articles. Abstract must be 120–160 words. Abstract must be unstructured and unreferenced.
Manuscript Manuscript must be 2,500–5,000 words, excluding the abstract, references, and accompanying statements. Text must be divided under headings and subheadings. Manuscript must include 3 to 7 keywords, and any use of AI tools in writing or drafting must be disclosed in the paper with the tool and its use described.
References Review Articles may include a maximum of 80 references. References must follow Vancouver style. References must be numbered in order of first mention using superscript, listed numerically at the end, and give the first three authors followed by "et al." unless there are four or fewer authors.
Figures & Tables Articles may include a maximum of 5 figures and tables combined. Figures must be uploaded separately and not included in the anonymised manuscript, while figure captions and tables must appear at the end of the anonymised manuscript file. Tables must be editable and figures and tables must be referenced within the manuscript text.
Reformat to Cardiac Failure Review using Livewrite Premium

Original Research

Cover Letter Cover Letter requirements are not specified.
Abstract A structured abstract is required for Original Research articles. Abstract must be 250 words. Abstract must be structured in five paragraphs. Abstract must use the headings Background, Methods, Results, Conclusion and Trial Registration.
Manuscript Manuscript must be 2,500–5,000 words excluding the abstract, references, and accompanying statements. Manuscript must include the headings Background, Methods, Results, Discussion, Study limitations, Conclusion, Trial Registration and Data availability statement, with Study limitations placed at the end of the Discussion. Manuscript must include 3 to 7 keywords, clinical perspectives as brief bullet points of no more than 150 words, and an AI-use disclosure if AI tools were used in writing or drafting.
References Original Research articles may include a maximum of 100 references. References must follow Vancouver style. References must be cited as superscript numbers in order of first mention and listed numerically at the end, with the first three authors followed by "et al." unless there are four or fewer authors.
Figures & Tables Articles may include a maximum of 5 figures and tables. Figures must be uploaded separately and not included within the anonymised manuscript file, while figure captions and tables must appear at the end of the anonymised manuscript file. Tables must be editable and tables longer than 2 pages must be uploaded as supplementary material.
Reformat to Cardiac Failure Review using Livewrite Premium

Letter To Editor

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract is not required for Letters To Editor.
Manuscript Letters To Editor must be no more than 1500 words. Manuscripts must include a minimum of 3 keywords and must disclose any use of AI tools in the paper, including how the tool was used and which tool was used.
References Letters To Editor may include a maximum of 10 references. References must follow the Vancouver referencing style. References must be cited as superscript numbers in order of first mention and listed numerically at the end, using the first three authors followed by "et al." unless there are four or fewer authors.
Figures & Tables Articles may include a maximum of 5 figures and tables. Figures must be uploaded separately and not included in the anonymised manuscript file, while tables with their titles or captions must appear at the end of the anonymised manuscript file. Figure titles and captions and table titles or captions must be included at the end of the anonymised manuscript file, and all figures and tables must be referenced in the manuscript text.
Reformat to Cardiac Failure Review using Livewrite Premium

Recent Publications

Multimodality Imaging in Hypertrophic Cardiomyopathy

Daniel Escribano, Elena Díaz-Peláez, Victoria Delgado

10.15420/cfr.2025.14
View Publication

A Contemporary Perspective on Acute Decompensated Heart Failure Classification: A State-of-the-art Review from an International Expert Group

Ovidiu Chioncel, Alexandre Mebazaa, Sean P Collins, Gad Cotter, Biykem Bozkurt, Maurizio Volterrani, Piotr Ponikowski, Oliviana Geavlete, Matteo Pagnesi, Giuseppe MC Rosano, Razvan I Radu, Magdy Abdelhamid, Marianna Adamo, Andrew P Ambrosy, Nicolas Girerd, Stefan D Anker, Beth Davison, Jan Biegus, Feras Bader, John Teerlink, Oscar Miro, Anika S Naidu, Mattia Arrigo, Gianluigi Savarese, Tuvia Ben Gal, G Michael Felker, Petar Seferovic, Mandeep R Mehra, Javed Butler, Andrew JS Coats, Marco Metra

10.15420/cfr.2025.50
View Publication

Integrated Cardio-oncology Service

Lloyd E Butel-Simoes, Joshua D Bennetts, Amanda Croft, Trent D Williams, Wojt Janowski, Jarad Martin, James Lynam, Doan TM Ngo, Aaron L Sverdlov

10.15420/cfr.2025.44
View Publication

Comprehensive Management of Hyperkalaemia in Patients with Chronic Kidney Disease and Cardiovascular Conditions: Expert Recommendations from Mexico

Antonio Méndez-Durán, Juan B Ivey-Miranda, Genaro H Mendoza-Zavala, Amada Álvarez-Sangabriel, Diana C Sánchez-Guerrero, Juan D Díaz-García, Julián A Borges-Vela, Luis E Morales-Buenrostro, Mateo Quilantán-Rodríguez, Ramón Ruíz-Mejía, Sergio A Chávez-Leal

10.15420/cfr.2025.03
View Publication

Lipoprotein(a): A Novel Risk Factor for Heart Failure and Biomarker of Prognosis? From Pathophysiology to Clinical Practice

Anna Kowalczys, Joanna Marlęga-Linert, Marcin Gruchała, Agnieszka Mickiewicz

10.15420/cfr.2025.46
View Publication

Frequently asked questions

How long does it take to publish?

Accepted articles will not be published until payment has been received.

Reformat to Cardiac Failure Review using Livewrite Premium

Is a cover letter required?

A rebuttal letter is required for revised submissions in response to reviewer comments.

Reformat to Cardiac Failure Review using Livewrite Premium

What are the publication costs?

Review article and original research: £2400 / €2800 / $3030; Expert opinion: £1800 / €2100 / $2273; Editorial, letter to editor, and viewpoint: no fee. A CC BY 4.0 option for UKRI and Wellcome Trust funded submissions costs £2800 / €3270 / $3535.

Reformat to Cardiac Failure Review using Livewrite Premium

Research Topics

Heart Failure Treatment and Management Cardiovascular Function and Risk Factors Cardiac pacing and defibrillation studies Mechanical Circulatory Support Devices Cardiac Structural Anomalies and Repair Diabetes Treatment and Management Cardiac Imaging and Diagnostics Cardiac Valve Diseases and Treatments Potassium and Related Disorders Cardiac Arrest and Resuscitation Cardiovascular and exercise physiology Cardiac Arrhythmias and Treatments Cardiomyopathy and Myosin Studies Cardiac Fibrosis and Remodeling Cardiac electrophysiology and arrhythmias Obstructive Sleep Apnea Research Atrial Fibrillation Management and Outcomes Cardiac Health and Mental Health Electrolyte and hormonal disorders COVID-19 Clinical Research Studies Pulmonary Hypertension Research and Treatments Frailty in Older Adults Viral Infections and Immunology Research Chemotherapy-induced cardiotoxicity and mitigation Hormonal Regulation and Hypertension

Related Journals

JO
Journal Of The American Heart Association Ovid Technologies (Wolters Kluwer)
JO
Journal Of Heart And Lung Transplantation ELSEVIER
CR
Cardiovascular Research Oxford University Press
CD
Cardiovascular Diabetology BioMed Central
JC
Jama Cardiology American Medical Association
EJ
European Journal Of Heart Failure Elsevier BV